Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection
The joint initiative is called J-ARC Healthcare Solutions
100% efficacy against severe Covid-19 disease and hospitalizations
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
The transaction as well as the open offer is expected to be completed by June this year.
Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants
Suvinys Developers will supply dydrogesterone to Jagsonpal Pharma as per the terms and conditions mentioned in the agreement.
The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines
Evonik invests in start-up to improve patient recovery after open-chest surgery
Subscribe To Our Newsletter & Stay Updated
